450 results on '"BASSET-SEGUIN, Nicole"'
Search Results
2. Genomic profiling of a skin adnexal carcinomas cohort using a comprehensive high throughput sequencing approach
3. Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629
4. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
5. Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma
6. Response to “Hedgehog pathway inhibitor real-world treatment patterns in patients with basal cell carcinoma: a claims-based analysis”
7. Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
8. Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.
9. Risk behaviour and patient preferences for an improved non-melanoma skin cancer prevention modality for organ-transplanted patients: a European, multi-country, online patient community study
10. Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas
11. Successful Treatment of Generalized Eruptive Keratoacanthoma of Grzybowski with Acitretin
12. New Vision in Photoprotection and Photorepair
13. Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study
14. Supplementary Figure from Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
15. Supplementary Data from Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
16. Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up
17. Phase 2 confirmatory study of cemiplimab (350 mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6
18. Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
19. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
20. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
21. Osteopenia and fractures associated with long-term therapy with MEK inhibitors
22. Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
23. Autoimmune diabetes induced by PD-1 inhibitor—retrospective analysis and pathogenesis: a case report and literature review
24. Eruptive squamous cell carcinomas following an acute skin inflammatory disease: A series of four cases
25. Development of a core outcome set for basal cell carcinoma
26. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
27. New Trends in the Susceptibility to Melanoma
28. Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination
29. Focal necrotizing myopathy with ‘dropped-head syndrome’ induced by cobimetinib in metastatic melanoma
30. Defining and recognising locally advanced basal cell carcinoma
31. Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
32. PARKIN Inactivation Links Parkinson’s Disease to Melanoma
33. Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.
34. The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997–2010
35. European Dermatology Forum guidelines on topical photodynamic therapy
36. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in Southern European populations: Results from a Meta-analysis
37. Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids
38. Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
39. Recent Advanced in the Treatment of Advanced SCC Tumors
40. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
41. Fréquence et caractérisation des patients atteints de carcinome basocellulaire avancé dont la meilleure réponse sous inhibiteurs de la voie Hedgehog est la progression
42. Traitement par sonidégib des carcinomes basocellulaires localement avancés : étude rétrospective monocentrique
43. Carcinomes épidermoïdes éruptifs dans un contexte de dermatose inflammatoire aiguë : une série de 4 cas
44. Update of the European guidelines for basal cell carcinoma management: Developed by the Guideline Subcommittee of the European Dermatology Forum
45. 26206 Effect of sonidegib on secondary tumor size endpoints through 12 weeks of treatment in patients with nevoid basal cell carcinoma syndrome
46. 26211 Pharmacokinetics of sonidegib in patients with nevoid basal cell carcinoma syndrome
47. Efficacy and safety of methyl-aminolevulinate cream activated by daylight in actinic keratosis: Two randomized, investigator blinded, controlled, phase 3 studies in Europe and Australia: 858
48. Safety of follow-up field application of ingenol mebutate 0.015% gel for actinic keratoses on face and scalp: 604
49. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: 30-month final update of the pivotal ERIVANCE BCC study: 1497
50. Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.